Cancer Therapy Evaluation Program: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

6 February 2025

  • curprev 23:1223:12, 6 February 2025MrT talk contribs 3,945 bytes −26 No edit summary
  • curprev 23:1223:12, 6 February 2025MrT talk contribs 3,971 bytes −12 No edit summary
  • curprev 23:1123:11, 6 February 2025MrT talk contribs 3,983 bytes +3,983 Created page with "{{Program |ProgramName=Cancer Therapy Evaluation Program |ProgramType=Program |OrgSponsor=National Cancer Institute |CreationLegislation=Established within the National Cancer Act of 1971 |Purpose=To facilitate the development of new cancer treatments by coordinating and funding clinical trials, managing the supply of investigational agents, and fostering collaborations between researchers, pharmaceutical companies, and academic institutions. The program aims to improve..."